Loredana Spadola
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Computational Drug Discovery Methods, Herpesvirus Infections and Treatments, Inflammatory mediators and NSAID effects, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → Small Molecule Binding Sites on the Ras:SOS Complex Can Be Exploited for Inhibition of Ras Activation(2015)118 cited
- → Synthesis and in Vitro Characterization of Organometallic Rhenium and Technetium Glucose Complexes against Glut 1 and Hexokinase(2004)80 cited
- → An improved model for fragment-based lead generation at AstraZeneca(2016)77 cited
- → Novel Prostaglandin D Synthase Inhibitors Generated by Fragment-Based Drug Design(2008)63 cited
- → Non-covalent inhibitors of rhinovirus 3C protease(2010)33 cited
- → Identification of cyclic peptides able to mimic the functional epitope of IgG1‐Fc for human FcyRI(2008)25 cited
- → Design of novel nicotinic ligands through 3D database searching(2004)14 cited
- → Homology modelling and docking studies on Varicella Zoster Virus Thymidine kinase(2003)10 cited
- → Functionalization of glucose for the labeling with 99mTc‐tricarbonyl(2001)6 cited
- → Extended Substrate Acceptance of Herpes Simplex Virus Type 1 Thymidine Kinase: a New Chance for Gene and Antiviral Therapy(2000)